VTE Prophylaxis in Post-Acute Care – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Pil Joo et al., adding:
“VTE prophylaxis in post-acute care: are we doing the right thing?
VTE prophylaxis is well established in acute care.
But what about the post-acute phase, when patients remain hospitalised after their acute needs have been addressed?
Evidence in this setting is surprisingly scarce.
A new study in RPTH Journal characterised VTE prophylaxis practices and outcomes in transitional care units (TCUs) at a Canadian tertiary care hospital.
Key findings from 1,218 patients:
- 72% received VTE prophylaxis during their TCU stay, primarily enoxaparin (85%)
- 75% of those remained on prophylaxis for their entire admission
- 90-day PE and DVT incidence were both low (0.8% and 0.9%, respectively) and similar between prophylaxis and non-prophylaxis groups
- Bleeding complications were equally rare and comparable between groups
The reality is that most post-acute care patients are elderly, with higher bleeding risk and lower mobility, yet they are routinely anticoagulated based on protocols designed for acute care.”
Title: Venous thromboembolism prophylaxis in postacute care units: a health record review
Authors: Pil Joo, Kathleen Qu, Jacob Stasso, Tenaaz Irani, Sanmeet Chahal, Tim Ramsay, Lana Castellucci

Other posts featuring RPTH Journal on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering